title: Is asymptomatic vasospasm associated with poor outcome in subarachnoid hemorrhage?
abstract: BACKGROUND
  Vasospasm occurs in up to 70% of aneurysmal subarachnoid hemorrhage (aSAH), but only half becomes symptomatic. It is unclear whether asymptomatic vasospasm (AV) detected by noninvasive testing affects outcome. Prophylactic hemodilutional, hypertensive, and hypervolemic (HHH) therapy is widely used but the benefit remains unproven. We aim to determine whether AV increases the risk of poor outcome and whether HHH is safe.
  
  
  METHODS
  A total of 175 consecutive patients with aSAH without clinical vasospasm were included. Patients with sonographic (transcranial doppler) or radiologic (computed tomography [CT] Angiography) vasospasm were assigned to AV group, while those without were assigned to no vasospasm (NV) group. Logistic regression was used to determine the association between AV and HHH on poor outcome, defined as modified Rankin scale (mRS) >3 at discharge or 3 to 6 months' follow-up.
  
  
  RESULTS
  In all, 106 patients had NV and 25 received HHH. A total of 69 patients had AV and 54 received HHH. Asymptomatic vasospasm compared to NV was not associated with poor outcome (odds ratio [OR] 2.6, 95% confidence interval [CI]: 0.75-8.9; P = .1). Hemodilutional, hypertensive, and hypervolemic use in patients with AV did not improve the outcome (OR 0.16, 95%CI: 0.009-2.84; P = .2). In patients with NV, HHH use showed trend toward poor outcome after multivariable adjustment (OR 12.6, 95%CI: 1.08-146.5 P = .04).
  
  
  CONCLUSIONS
  Asymptomatic vasospasm does not appear to be associated with poor outcome in aSAH. Hemodilutional, hypertensive, and hypervolemic therapy in AV was not associated with improved outcome and may be harmful to patients who do not have vasospasm. Further research is needed to validate this finding.
authors: Department of Neurology, Upstate Medical University, Syracuse, NY, USA.
authors: Julius Gene S
authors: JG
authors: Latorre
authors: Yahia
authors: Y
authors: Lodi
authors: Ziad
authors: Z
authors: El-Zammar
authors: Ashok
authors: A
authors: Devasenapathy
keywords: cerebrovascular disorders; clinical specialty; intracranial; neurocritical care; subarachnoid hemorrhage; vasospasm
references: Stroke. 2000 Feb;31(2):383-91
references: 10657410
references: Crit Care Med. 2007 Aug;35(8):1985-6
references: 17667248
references: Stroke. 1994 Nov;25(11):2315-28
references: 7974568
references: J Neurosurg. 2003 May;98(5):978-84
references: 12744357
references: Crit Care Med. 2009 Feb;37(2):432-40
references: 19114880
references: Crit Care Med. 2007 Aug;35(8):1844-51; quiz 1852
references: 17581487
references: J Clin Epidemiol. 2008 Apr;61(4):344-9
references: 18313558
references: J Neurosurg. 2008 Dec;109(6):1052-9
references: 19035719
references: Acta Neurochir (Wien). 2002 Jul;144(7):703-12; discussion 712-3
references: 12181704
references: Stroke. 2009 Mar;40(3):994-1025
references: 19164800
references: Neurosurgery. 2001 Sep;49(3):593-605; discussion 605-6
references: 11523669
references: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD000483
references: 15494997
references: Neurosurg Focus. 2006 Sep 15;21(3):E1
references: 17029333
references: Br J Neurosurg. 1995;9(3):403-12
references: 7546361
references: Neurosurgery. 2007 Jan;60(1):91-7; discussion 97-8
references: 17228256
references: Neurosurgery. 2001 Dec;49(6):1341-8; discussion 1348-50
references: 11846933
references: J Neurosurg. 1968 Jan;28(1):14-20
references: 5635959
references: Eur J Ultrasound. 2002 Nov;16(1-2):3-10
references: 12470845
references: J Neurosurg. 2005 Dec;103(6):974-81
references: 16381183
references: Neurosurgery. 1980 Jan;6(1):1-9
references: 7354892
references: Stroke. 2009 Apr;40(4):1526-9
references: 19095984